ProKidney (PROK) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
ProKidney Corp. has moved to motivate and retain key staff by approving a new Supplemental Equity Award for certain employees, including the Chief Legal Officer Todd Girolamo. This award, part of the 2022 Incentive Equity Plan, grants options for employees to buy shares at market value, with a vesting period that begins on March 1, 2025, for half of the shares, followed by monthly installments over the next year.
For further insights into PROK stock, check out TipRanks’ Stock Analysis page.
